FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
This Quarter Return
-1.37%
1 Year Return
+33.53%
3 Year Return
+83.32%
5 Year Return
+196.78%
10 Year Return
+650.37%
AUM
$202M
AUM Growth
+$202M
(+10%)
Cap. Flow
+$23.1M
Cap. Flow
% of AUM
11.47%
Top 10 Holdings %
Top 10 Hldgs %
29.52%
Holding
189
New
37
Increased
84
Reduced
33
Closed
9
Top Buys
| 1 |
BridgeBio Pharma
BBIO
|
$2.04M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$1.76M |
| 3 |
Boston Scientific
BSX
|
$1.26M |
| 4 |
Apple
AAPL
|
$854K |
| 5 |
Microsoft
MSFT
|
$800K |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$594K |
| 2 |
Align Technology
ALGN
|
$274K |
| 3 |
Bread Financial
BFH
|
$272K |
| 4 |
CELG
Celgene Corp
CELG
|
$270K |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$229K |
Sector Composition
| 1 | Healthcare | 22.94% |
| 2 | Technology | 8.76% |
| 3 | Consumer Discretionary | 6.47% |
| 4 | Energy | 6.3% |
| 5 | Consumer Staples | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $15.9M | 7.9% |
328,562
+657
| +0.2% | +$31.9K |
|
|
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $10.1M | 5% |
375,811
-6,100
| -2% | -$164K |
|
3
iShares Core S&P 500 ETF
IVV
$662B
| $5.72M | 2.84% |
19,168
-76
| -0.4% | -$22.7K |
|
|
MYOK
4
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $5.68M | 2.81% |
108,853
-11,395
| -9% | -$594K |
|
5
Meta Platforms (Facebook)
META
$1.86T
| $4.48M | 2.22% |
25,131
+1,124
| +5% | +$200K |
|
6
Texas Pacific Land
TPL
$21.5B
| $3.9M | 1.93% |
6,007
+405
| +7% | +$263K |
|
7
Visa
V
$683B
| $3.82M | 1.9% |
22,228
+1,700
| +8% | +$292K |
|
8
iShares US Consumer Staples ETF
IYK
$1.35B
| $3.48M | 1.72% |
27,482
+700
| +3% | +$88.5K |
|
9
Amazon
AMZN
$2.44T
| $3.25M | 1.61% |
1,872
+295
| +19% | +$512K |
|
10
CVS Health
CVS
$92.8B
| $3.2M | 1.59% |
50,785
+645
| +1% | +$40.7K |
|
11
Vanguard Mega Cap Growth ETF
MGK
$28.9B
| $3.1M | 1.54% |
23,371
+1,821
| +8% | +$242K |
|
12
Altria Group
MO
$113B
| $3.05M | 1.51% |
74,481
+2,235
| +3% | +$91.4K |
|
13
Gilead Sciences
GILD
$140B
| $2.87M | 1.42% |
45,315
+3,446
| +8% | +$218K |
|
14
iShares Select Dividend ETF
DVY
$20.8B
| $2.8M | 1.39% |
27,460
+1,060
| +4% | +$108K |
|
15
iShares Russell 2000 ETF
IWM
$67B
| $2.65M | 1.32% |
17,531
-269
| -2% | -$40.7K |
|
16
Union Pacific
UNP
$133B
| $2.63M | 1.3% |
16,216
+500
| +3% | +$81K |
|
17
Johnson & Johnson
JNJ
$427B
| $2.63M | 1.3% |
20,295
+2,134
| +12% | +$276K |
|
|
18
Apple
AAPL
$3.45T
| $2.54M | 1.26% |
11,341
+3,814
| +51% | +$854K |
|
19
Dayforce
DAY
$11B
| $2.52M | 1.25% |
51,040
+3,100
| +6% | +$153K |
|
20
Alphabet (Google) Class A
GOOGL
$2.57T
| $2.47M | 1.22% |
2,023
+123
| +6% | +$150K |
|
21
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $2.43M | 1.21% |
12,585
-152
| -1% | -$29.4K |
|
22
Philip Morris
PM
$260B
| $2.41M | 1.2% |
31,781
+2,650
| +9% | +$201K |
|
23
iShares Russell 1000 ETF
IWB
$43.2B
| $2.38M | 1.18% |
14,436
+24
| +0.2% | +$3.95K |
|
24
Ares Capital
ARCC
$15.8B
| $2.37M | 1.17% |
127,070
+17,133
| +16% | +$319K |
|
25
Medtronic
MDT
$119B
| $2.21M | 1.09% |
20,313
+3,249
| +19% | +$353K |
|